Baclofen formulations and methods of minimizing patient exposure to metabolite variations | Patent Number 11850225

US 11850225 B2
Application Number17861844
Publication NumberUS 20230103372 A1
Pendency1 year, 5 months, 18 days
Filled DateJul 11, 2022
Priority DateSep 29, 2021
Publication DateApr 6, 2023
Expiration DateSep 28, 2041
Inventor/ApplicantsLeonard O'Mahony
John DEVANE
Leonard O'MAHONY
Sharon Hamm
Wolfgang Mohr
Sharon HAMM
David PENAKE
David Penake
Manuel Weinheimer
John Devane
ExaminesRAMACHANDRAN, UMAMAHESWARI
Art Unit1627
Technology Center1600
Assignments
Truist Financial Corporation
Current
Amneal Pharmaceuticals
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.